RESEARCH LIBRARY / THAILAND

Buy Tirzepatide in Thailand

An evidence-led guide to tirzepatide research, dual GIP/GLP-1 receptor activity, Thai regulation and laboratory quality information.
Research overview · Clinical evidence · Regulatory considerations · Scientific references

Tirzepatide product and delivery in Thailand

Delivery across Thailand

Bangkok
Same-day delivery where available.

Nationwide
Typically 1–3 days, depending on destination and dispatch time.

Discreet packaging and delivery updates.

View delivery information
Buy peptides in Thailand – Tirzepatide 10 mg | Thai Peptides

Tirzepatide

10 mg · ฿2,000 per vial
Current listed strength and price.

View Tirzepatide

Tirzepatide 10 mg: product specifications

CompoundTirzepatide
Strength10 mg
Listed price฿2,000 per vial
Receptor activityGIP + GLP-1

View current product details and availability

Research material and not equivalent to an authorised prescription medicine.

Tirzepatide at a glance

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research. Approved prescription formulations exist, but research-labelled vials are not equivalent to authorised medicines.
Compound: Tirzepatide
Mechanism: GIP and GLP-1 receptor agonism
Research: Metabolic and glucose regulation pathways
Thai status: Check approval for each specific medicinal product with the Thai FDA.

What is Tirzepatide?

Tirzepatide activates GIP and GLP-1 receptors, which are involved in glucose regulation, appetite signalling and metabolic research.

Two receptors, one dual-agonist molecule

GIP: Incretin receptor pathway involved in insulin and metabolic signalling.

GLP-1: Involved in glucose regulation, gastric emptying and appetite signalling.

What does clinical research show?

The Phase 3 SURMOUNT-1 trial followed 2,539 participants for 72 weeks and reported substantial average body-weight reductions in supervised clinical trial groups. Results do not establish the safety or effectiveness of independently sold research vials.
The most frequently reported adverse events in the SURMOUNT-1 trial were gastrointestinal and often occurred during dose escalation. Research results do not establish the sterility or safety of a separately supplied vial.
Read the published Phase 2 study

Tirzepatide compared with Retatrutide

Tirzepatide targets two receptors (GIP and GLP-1), while investigational retatrutide targets three (GIP, GLP-1 and glucagon). Results across different trials are not directly comparable.

Regulatory status in Thailand

The Thai FDA regulates tirzepatide-containing medicines. Approval of a prescription formulation does not mean that a separately sold research vial is approved or lawful to import or supply.
Thai Food and Drug Administration

Understanding purity and batch testing

Batch-specific certificates of analysis can document identity and purity measurements. Check the laboratory, batch number, method and report date. Purity reports alone do not establish sterility or regulatory approval.

Understanding batch verification

A certificate of analysis should identify the testing laboratory, batch number, test date and method. Compare the report with the supplied batch. A purity result does not prove sterility, safety or Thai FDA approval.

Laboratory storage and handling

Storage depends on the particular formulation and validated manufacturer instructions. Research materials and authorised prescription products may have different requirements.

Frequently asked questions

Tirzepatide 10 mg is currently listed on our website.

The listed price is ฿2,000 per 10 mg vial.

Bangkok same-day may be available; nationwide delivery is typically 1–3 days, subject to courier coverage.

Tirzepatide activates GIP and GLP-1 receptors.

Ask for a certificate of analysis matching the specific batch. Purity testing alone does not prove sterility.

A research-labelled vial is not equivalent to an authorised prescription medicine.

Scientific sources and further reading

SURMOUNT-1 Phase 3 clinical trial, NEJM (2022)

Long-term SURMOUNT-1 follow-up, NEJM

Thai Food and Drug Administration

Related research: Retatrutide in Thailand